Interferon-gamma gene polymorphism in Iranian patients with multiple sclerosis

ABSTRACT

Interferon- gamma [IFN- gamma] is an important immune regulator and inflammatory cytokine which is implicated in the pathogenesis of multiple sclerosis [MS]. A single nucleotide polymorphism, T to A, at position +874 in the first intron has previously been shown. This polymorphism is associated with IFN- gamma production level. To study the effect of this polymorphism on susceptibility to multiple sclerosis, we screened genomic DNA samples from clinically definite MS patients and their unaffected first-degree relatives as controls, using sequence-specific primers [PCR-SSP]. The results indicated that MS patients showed a lower TT [21.2% vs. 30.3%] and higher AA [21.2% vs. 12.1%] genotypes compared to controls, although there were statistically no differences in the IFN- gamma genotype distribution between these two groups. Thus, our data indicate that there is no association between IFN- gamma +874 polymorphism and MS susceptibility or severity of the disease